Spotlight on CB 2782-PEG – A Complement Factor C3- Inactivating Protease for Dry AMD

Time: 11:45 am
day: Track 1 Day 1 AM


  • Discuss the pre-clinical development and evaluation of CB 2782-PEG
  • Examine Molecular design of CB 2782-PEG
  • Evaluate the advantage of protease therapeutics to regulate biological cascades and processes